Ovid Application Error
Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia.
Yang, Renchi; Li, Junmin; Jin, Jie; Huang, Meijuan; Yu, Ziqiang; Xu, Xiaojun; Zhang, Xiaohui; Hou, Ming
British Journal of Haematology.
176(1):101-110, January 2017.
(Format: HTML, PDF)